◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Target Healthcare REIT Ord (THRL) Financial History

Name: Target Healthcare REIT Ord (THRL) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

— · DATA UPDATED 2026-08-16

Target Healthcare REIT Ord (THRL) operates in the — industry. Its market capitalization is roughly £692 million. In the fiscal year ended 2024-06-30, THRL reported £78M in revenue and £73M in net income.

Interactive charts & full statements →

THRL Revenue & Earnings History — Annual Income Statement

Income statement	2024-06-30	2023-06-30	2022-06-30
Total Revenue	£78M	(£2M)	£56M
Net Income	£73M	(£7M)	£49M

GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

THRL Free Cash Flow History

Cash flow	2024-06-30	2023-06-30	2022-06-30
Dividends Paid	(£35M)	(£40M)	(£40M)

GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

THRL Balance Sheet History

Balance sheet	2024-06-30	2023-06-30	2022-06-30
Total Assets	£967M	£908M	£964M
Total Liabilities	£278M	£253M	£265M

GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive THRL viewer.

Other Companies in Software & IT Services

CGT · Capital Gearing Ord — $818 million
SAIN · Scottish American Ord — $816 million
GSCT · The Global Smaller Companies Trust Ord — $815 million
BGFD · Baillie Gifford Japan Ord — $699 million
BUT · Brunner Ord — $674 million
JEGI · JPMorgan European Growth & Income Ord — $629 million
AAS · Aberdeen Asia Focus PLC — $615 million
JEDT · JPMorgan European Discovery Ord — $571 million

← THO All “T” companies THRM →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.